Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/VYNE-THERAPEUTICS-INC-40331628/news/VYNE-Therapeutics-Announces-Positive-Data-from-Phase-1b-Trial-for-Novel-BET-Inhibitor-VYN201-in-Pati-45184011/?utm_source=whatsapp&utm_medium=social&utm_campaign=share